R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples